Q4 2025 Conmed Corp Earnings Call Transcript
Key Points
- Conmed Corp (CNMD) reported a 7.9% year-over-year increase in total sales for the fourth quarter, with full-year sales reaching $1.375 billion, representing a 5.2% growth.
- Orthopedic sales increased by 12.1% in the fourth quarter and 5.5% for the full year, indicating strong performance in this segment.
- The company made significant progress in resolving supply chain constraints, reducing backorder value and SKUs to a three-year low.
- Conmed Corp (CNMD) is focusing on high-growth, high-margin markets such as robotic and laparoscopic surgery, smoke evacuation, and orthopedic soft tissue repair.
- The company has a strong cash flow, with leverage reduced to 2.9 times, providing flexibility for innovation, growth, and capital returns.
- The decision to exit the gastroenterology product lines is expected to create near-term earnings dilution.
- Fourth quarter adjusted gross margin decreased by 100 basis points due to tariff impacts.
- US general surgery sales declined by 0.4% in the fourth quarter, driven by non-focus areas like OEM smoke evacuation SKUs.
- The company is facing challenges in achieving a world-class supply chain, although progress has been made.
- GAAP net income for the fourth quarter and full year decreased significantly compared to the previous year, indicating potential profitability issues.
Thank you for standing by. Welcome to Conmed's fourth quarter fiscal 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans, and objectives. These statements represent the forward-looking statements that involve risk and uncertainties as those terms are defined under the federal securities laws.
Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance, or results. The company's actual results may differ materially from its current expectations. Please refer to the risk and other uncertainties disclosed under the forward-looking information and today's press release, as well as the company's SEC filings for more details on the risk and uncertainties that may cause actual results of differ materially.
The company disclaims any obligation to update any forward-looking statements that may be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
